サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1114610

ポイントオブケア検査 (POCT) の世界市場 (診断セグメント別、モード別、プラットフォーム別、エンドユーザー別、地域別)：新型コロナウイルス感染症 (COVID-19) の影響、最新動向、企業プロファイル - 将来予測 (2028年まで)

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028
出版日: | 発行: iGate Research | ページ情報: 英文 270 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
ポイントオブケア検査 (POCT) の世界市場 (診断セグメント別、モード別、プラットフォーム別、エンドユーザー別、地域別)：新型コロナウイルス感染症 (COVID-19) の影響、最新動向、企業プロファイル - 将来予測 (2028年まで)
出版日: 2022年08月16日
発行: iGate Research
ページ情報: 英文 270 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のポイントオブケア検査 (POCT) 市場は、2028年までに約650億米ドルに達すると予測されています。ポイントオブケア (POC) 検査は、正確で迅速な検査に対する需要が病院内外で高まり、過去20年間で急成長しています。POCTまたはベッドサイド検査は、医師や医療スタッフが数分以内に検査室品質の診断結果をリアルタイムで正しく得ることができる医療診断検査です。

近年、持ち運び可能な検査機器の導入が進み、POC検査は病院から職場、家庭、災害時、そして最近ではコンビニエンスストアなど、さまざまな医療環境へと移行しています。さらに、インドや中国などの新興諸国では、感染症や心血管疾患、糖尿病などの慢性疾患の発生率が上昇しており、POC検査サービスの需要を喚起しています。したがって、感染症や慢性疾患の増加は、近い将来、Point of Care Testing市場を強化することになるでしょう。

POCT市場：診断セグメント別の予測

診断セグメントに基づくと、市場は血糖値検査セグメントによって支配されています。先進国と同様に経済諸国でも糖尿病の有病率が増加しており、患者の在宅検査への傾斜が高まっていることが、予測期間中にセグメントの成長を促進する主要な促進要因となっています。また、感染症セグメントは、2021年に2番目に大きな収益シェアを占めました。一方、心臓マーカーセグメントは、予測期間中に大きな成長を遂げることが期待されています。

POCT市場：モード別の予測

モード別では、市場はPOTCベース検査のセグメントによって支配されています。このセグメントは費用対効果に優れているだけでなく、簡単に操作できることから、2021年のPOCT市場全体を支配しています。高いセグメント成長率は、血糖値検査や妊娠検査など、数秒で結果が得られるOTC検査が増加していることに起因しています。

POCT市場：プラットフォーム別の予測

プラットフォーム別では、ラテラルフローアッセイ (LFA) 分野が2021年に最大の収益シェアを占めています。ラテラルフローアッセイに基づくPOC検査は、長時間に及ぶ従来の検査室プロセスに代わるものとして採用が進んでいます。また、イムノアッセイ技術のPOCT市場は、予測期間中に大きな成長を遂げると予想されます。

POCT市場：エンドユーザー別の予測

POCT市場は病院がその大半を占め、診療所がそれに続いています。がんや心血管疾患など、適切なモニタリングを必要とする慢性疾患の有病率が上昇し、病院やクリニックで低侵襲な処置が行われることが望ましいとされています。在宅医療分野は、在宅および遠隔モニタリングへの嗜好の高まりと、ホームケアユーザーの間での迅速な検査に対する需要の高まりにより、予測期間中に最も高い成長率を示すと予想されます。

POCT市場：地域別の予測

POCT市場は、地域別では北米が支配的であり、予測期間中もその地位を維持すると予想されます。これは、携帯可能で迅速な診断を必要とする慢性疾患や感染症の有病率の上昇、製品承認の増加、この地域におけるPOCTの採用を支援する政府の取り組みが活発化していることに起因していると思われます。欧州は、POCT市場で2番目に高いシェアを占めています。アジア太平洋地域のPOCT市場は、高齢者人口の増加、対象疾患の有病率の上昇、在宅医療需要の増加、先進技術を搭載した新製品の導入などにより、予測期間中に最も速い速度で成長すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 世界のポイントオブケア検査市場に対するCOVID-19の影響

第3章 世界のポイントオブケア検査の市場と予測 (2010年～2028年)

第4章 世界のポイントオブケア検査の市場シェアと予測 (2010年～2028年)

第5章 世界のポイントオブケア検査の市場と予測：診断セグメント別 (2010年～2028年)

  • 血糖検査
  • 心臓マーカー検査
  • 脂質パネル/コレステロール検査
  • 凝固検査
  • 感染症検査
  • 尿検査
  • 乱用薬物検査
  • 便潜血検査
  • 妊娠・不妊検査
  • 腫瘍マーカー検査
  • 救急救命検査
  • HbA1c検査
  • 臨床化学検査
  • ビリルビン検査
  • 血液検査

第6章 世界のポイントオブケア検査の市場と予測：モード別 (2010年～2028年)

  • 処方箋ベース検査
  • OTCベース検査

第7章 世界のポイントオブケア検査の市場と予測：プラットフォーム別 (2015年～2028年)

  • ラテラルフローアッセイ
  • イムノアッセイ
  • マイクロフルイディクス
  • ディップスティック
  • 分子診断
  • 他のプラットフォーム

第8章 世界のポイントオブケア検査の市場と予測：エンドユーザー別 (2010年～2028年)

  • 病院
  • 診療所
  • 検査室
  • 介護付き住宅
  • 在宅医療

第9章 世界のポイントオブケア検査の市場と予測：地域別 (2010年～2028年)

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 世界のポイントオブケア検査市場：最近の動向

第11章 ポイントオブケア検査市場：企業プロファイル

  • Abbott Laboratories
    • 企業概要
    • 製品ポートフォリオ
    • 財務分析
    • 事業戦略
  • Siemens Healthineers
  • Roche Diagnostics
  • Quest Diagnostics
  • Becton, Dickinson and Company
  • ACON Laboratories
  • Abaxis, Inc.
  • Abingdon Health, Ltd.
  • Access Bio, Inc.
  • AccuBioTech Co, Ltd.
  • Akers Biosciences, Inc.
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • AmniSure International
  • Aquila Diagnostic Systems, Inc
  • ARKRAY Inc
  • Artron Laboratories Inc.
  • Ascensia Diabetes Care Holdings AG
  • Immune IQ (Formerly Ativa)
  • Atlas Link Biotech Co., Ltd
  • Audit Diagnostics
  • Augurix Diagnostics
  • Autobio Diagnostics Co., Ltd
  • Axxin
  • Beckman Coulter, Inc
  • Bhat Bio-Tech India Private Ltd. (BBI)
  • bioLytical Laboratories
  • BioMedomics, Inc
  • Biomerica, Inc.
  • bioMerieux SA
  • Biophor Diagnostics, Inc
  • Biosensia Ltd.
  • Bio-Rad Laboratories Inc.
  • Bioscan Screening Systems, Inc.
  • BTNX Inc.
  • Boditech Med Inc
  • Xiamen Boson Biotech Co. Ltd
  • Calypte Biomedical Corporation
  • Cepheid, Inc
  • Chembio Diagnostic Systems, Inc.
  • Clarity Diagnostics, LLC
  • Confirm Biosciences
  • CTK Biotech, Inc.
  • Daktari Diagnostics
  • Danaher Corporation
  • Dexcom, Inc
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc.
  • DNA Electronics Ltd. (DNAe)
  • EKF Diagnostics Holdings plc
  • ELITechGroup, Inc.
  • Eurolyser Diagnostica GmbH
  • Exact Sciences Corporation
  • Exalenz Bioscience Ltd.
  • Genedrive plc
  • GeTein BioMedical, Inc.
  • Helena Laboratories
  • Hemosure, Inc.
  • Immunostics, Inc.
  • Instrumentation Laboratory
  • JAL Innovation PTE LTD
  • Jant Pharmacal Corporation
  • LamdaGen Corporation
  • LifeScan, Inc
  • LifeSign, LLC
  • MBio Diagnostics, Inc (Now LightDeck Diagnostics)
  • Medix Biochemica
  • Medtronic, Inc.
  • A. Menarini Diagnostics S.R.L.
  • Meridian Bioscience, Inc
  • Nano-Ditech Corporation
  • Noble Medical, Inc
  • Nova Biomedical, Corp.
  • Oasis Diagnostics Corporation
  • OPKO Health, Inc
  • OPTI Medical Systems, Inc
  • OraSure Technologies, Inc
  • Polymed Therapeutics Inc.
  • Preventis GmbH
  • Princeton Biomeditech Corporation
  • QuantuMDx Group Limited
  • Radiometer Medical A/S
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics LLC
  • Siloam Biosciences, Inc
  • Sysmex Corporation
  • TECHLAB, Inc.
  • Teco Diagnostics
  • Trinity Biotech PLC
  • Trividia Health
  • Tulip Diagnostics Ltd
  • Veredus Laboratories PTE Ltd
  • Vircell
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Werfen
  • Quidel Corporation
  • Thermo Fisher Scientific
  • Mesa Biotech Inc.
  • GeneSTAT Molecular Diagnostics, LLC
  • Biocartis Group NV
  • Johnson and Johnson Service, Inc.

第12章 世界のポイントオブケア検査市場：促進要因

  • ポイントオブケア検査：未来への一歩
  • 慢性疾患・感染症の有病率の高さ
  • PoCの継続手的な拡大 (自己検査を含む)
    • ポイントオブケア検査の有望性
    • ポイントオブケア検査の将来性：「心配性の人々」
    • ハブとスポーク
    • 教育
  • 市場需要に拍車をかけるPOCTの技術的進歩

第13章 世界のポイントオブケア検査市場：課題

  • 低・中所得国におけるポイントオブケア (POC) 検査の障壁
    • PoC技術の普及拡大の障壁
    • ポイントオブケア検査の技術面・管理面・運用面の障壁
    • ポイントオブケア検査の医療制度関連の障壁
    • ポイントオブケア検査の経済的障壁
  • 政策/規制ガイドラインと資金調達の課題
  • PoC診断開発におけるインフラの障壁と課題
図表

List of Figures

List of Figures:

  • Figure 3-1: Global - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 3-2: Global - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 5-1: Global - Blood Glucose Testing Market (Million US$), 2010 - 2021
  • Figure 5-2: Global - Forecast for Blood Glucose Testing Market (Million US$), 2022 - 2028
  • Figure 5-3: Global - Cardiac Marker Testing Market (Million US$), 2010 - 2021
  • Figure 5-4: Global - Forecast for Cardiac Marker Testing Market (Million US$), 2022 - 2028
  • Figure 5-5: Global - Lipid Panel/Cholesterol Testing Market (Million US$), 2010 - 2021
  • Figure 5-6: Global - Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2022 - 2028
  • Figure 5-7: Global - Coagulation Testing Market (Million US$), 2010 - 2021
  • Figure 5-8: Global - Forecast for Coagulation Testing Market (Million US$), 2022 - 2028
  • Figure 5-9: Global - Infectious Disease Testing Market (Million US$), 2010 - 2021
  • Figure 5-10: Global - Forecast for Infectious Disease Testing Market (Million US$), 2022 - 2028
  • Figure 5-11: Global - Urinalysis Testing Market (Million US$), 2010 - 2021
  • Figure 5-12: Global - Forecast for Urinalysis Testing Market (Million US$), 2022 - 2028
  • Figure 5-13: Global - Drug of Abuse Testing Market (Million US$), 2010 - 2021
  • Figure 5-14: Global - Forecast for Drug of Abuse Testing Market (Million US$), 2022 - 2028
  • Figure 5-15: Global - Fecal Occult Blood Testing Market (Million US$), 2010 - 2021
  • Figure 5-16: Global - Forecast for Fecal Occult Blood Testing Market (Million US$), 2022 - 2028
  • Figure 5-17: Global - Pregnancy & Fertility Testing Market (Million US$), 2010 - 2021
  • Figure 5-18: Global - Forecast for Pregnancy & Fertility Testing Market (Million US$), 2022 - 2028
  • Figure 5-19: Global - Tumor Marker Testing Market (Million US$), 2010 - 2021
  • Figure 5-20: Global - Forecast for Tumor Marker Testing Market (Million US$), 2022 - 2028
  • Figure 5-21: Global - Critical Care Testing Market (Million US$), 2010 - 2021
  • Figure 5-22: Global - Forecast for Critical Care Testing Market (Million US$), 2022 - 2028
  • Figure 5-23: Global - HbA1c Testing Market (Million US$), 2010 - 2021
  • Figure 5-24: Global - Forecast for HbA1c Testing Market (Million US$), 2022 - 2028
  • Figure 5-25: Global - Clinical Chemistry Testing Market (Million US$), 2010 - 2021
  • Figure 5-26: Global - Forecast for Clinical Chemistry Testing Market (Million US$), 2022 - 2028
  • Figure 5-27: Global - Bilirubin Testing Market (Million US$), 2010 - 2021
  • Figure 5-28: Global - Forecast for Bilirubin Testing Market (Million US$), 2022 - 2028
  • Figure 5-29: Global - Hematology Testing Market (Million US$), 2010 - 2021
  • Figure 5-30: Global - Forecast for Hematology Testing Market (Million US$), 2022 - 2028
  • Figure 6-1: Global - Prescription-based Testing Market (Million US$), 2010 - 2021
  • Figure 6-2: Global - Forecast for Prescription-based Testing Market (Million US$), 2022 - 2028
  • Figure 6-3: Global - OTC-based Testing Market (Million US$), 2010 - 2021
  • Figure 6-4: Global - Forecast for OTC-based Testing Market (Million US$), 2022 - 2028
  • Figure 7-1: Global POCT - Lateral Flow Assays Market (Million US$), 2015 - 2021
  • Figure 7-2: Global POCT - Forecast for Lateral Flow Assays Market (Million US$), 2022 - 2028
  • Figure 7-3: Global POCT - Immunoassays Market (Million US$), 2015 - 2021
  • Figure 7-4: Global POCT - Forecast for Immunoassays Market (Million US$), 2022 - 2028
  • Figure 7-5: Global POCT - Microfluidics Market (Million US$), 2015 - 2021
  • Figure 7-6: Global POCT - Forecast for Microfluidics Market (Million US$), 2022 - 2028
  • Figure 7-7: Global POCT - Dipsticks Market (Million US$), 2015 - 2021
  • Figure 7-8: Global POCT - Forecast for Dipsticks Market (Million US$), 2022 - 2028
  • Figure 7-9: Global POCT - Molecular Diagnostics Market (Million US$), 2015 - 2021
  • Figure 7-10: Global POCT - Forecast for Molecular Diagnostics Market (Million US$), 2022 - 2028
  • Figure 7-11: Global POCT - Other Platforms Market (Million US$), 2015 - 2021
  • Figure 7-12: Global POCT - Forecast for Other Platforms Market (Million US$), 2022 - 2028
  • Figure 8-1: Hospitals - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-2: Hospitals - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 8-3: Clinics - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-4: Clinics - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 8-5: Laboratories - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-6: Laboratories - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 8-7: Assisted Living Healthcare Facilities - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-8: Assisted Living Healthcare Facilities - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 8-9: Home Care - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-10: Home Care - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-1: North America - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-2: North America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-3: Europe - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-4: Europe - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-5: Asia Pacific - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-6: Asia Pacific - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-7: Latin America - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-8: Latin America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-9: Middle East and Africa - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-10: Middle East and Africa - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 11-1: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2021
  • Figure 11-2: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
  • Figure 11-3: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2021
  • Figure 11-4: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
  • Figure 11-5: Roche Diagnostics - Global Sales (Million US$), 2013 - 2021
  • Figure 11-6: Roche Diagnostics - Forecast for Global Sales (Million US$), 2022 - 2028
  • Figure 11-7: Quest Diagnostics - Net Sales (Million US$), 2014 - 2021
  • Figure 11-8: Quest Diagnostics - Forecast for Net Sales (Million US$), 2022 - 2028
  • Figure 11-9: Becton, Dickinson and Company - Global Diagnostics Sales (Million US$), 2014 - 2021
  • Figure 11-10: Becton, Dickinson and Company - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028

List of Tables:

  • Table 4-1: By Diagnostics Segment - Global Point of Care Testing Market Share (Percent), 2010 - 2021
  • Table 4-2: By Diagnostics Segment - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 4-3: By Mode - Global Point of Care Testing Market Share (Percent), 2010 - 2021
  • Table 4-4: By Mode - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 4-5: By Platform - Global Point of Care Testing Market Share (Percent), 2015 - 2021
  • Table 4-6: By Platform - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 4-7: By End Users - Global Point of Care Testing Market Share (Percent), 2010 - 2021
  • Table 4-8: By End Users - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 4-9: By Region - Point of Care Testing Market Share (Percent), 2010 - 2021
  • Table 4-10: By Region - Forecast for Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 11-1: Eurolyser Diagnostica GmbH - Point-of-Care Test Portfolio
  • Table 13-1: POCT - Barriers to Adoption and Scale-up of POC Technologies
目次

The global point of care testing (POCT) market is predicted to reach nearly US$ 65 Billion by 2028. Point-of-care (POC) testing has skyrocketed in the last 20 years as demand for accurate and fast testing has blossomed both inside and outside the hospital setting. POCT or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours.

Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Furthermore, rising incidence of infectious diseases and chronic conditions such as cardiovascular diseases and diabetes in developing countries such as India and China have stimulated demand for point of care testing services. As per statistics of the International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes globally, and it is estimated to reach 643 million by 2030 and 783 million by 2045. Hence, growing infectious diseases and chronic conditions will enhance the point of care testing market in the near future.

Impact of COVID-19 on Global Point of Care Testing Market

The COVID-19 outbreak has become a global stress test. The disease has infected around 596.2 million people worldwide. Globally the death toll has reached 6,456,879 according to the latest statistics from the Worldometers (as of August 16, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak stirred an unprecedented public health concern across the globe and has positively impacted the point of care testing market growth.

The need for speedy diagnostic results has made point-of-care testing a vital diagnostic tool. The novel coronavirus has accelerated the research and development activities in the point-of-care diagnostics market. The usage of POC kits in COVID-19 diagnosis has increased at a significant pace owing to multiple advantages such as smaller size, portability, convenience, and precise outcomes, among others. These tests are capable of operating in any low-resource setting including home care settings and are needed to adequately combat the COVID-19 pandemic.

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment. Increasing prevalence of diabetes in developing as well as developed economies and the rising inclination of patients towards home testing is the major driver that will drive segmental growth over the forecast timeframe.

The infectious diseases segment held second largest revenue share in 2021. Infectious diseases are the primary cause of mortality globally, and according to figures from the Clinical Microbiology and Infection journal, they claim over 14 million lives annually, making up around 25% of the 56 million deaths recorded worldwide. Infectious disease testing has shifted from centralized to decentralized POC testing, resulting in better patient care. The market is being driven by increased demand for quick tests, which has prompted industry players to deliver POC solutions to decentralized regions. For instance, Abbott has introduced ID NOW, the world's quickest molecular POC test, which provides COVID-19 findings in 13 minutes and is usable in a variety of decentralized healthcare settings.

Cardiac marker segment is expected to grow at a significant rate during the forecast period. The growing prevalence of cardiovascular ailments, increasing purchasing power, rise in the geriatric population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas is expected to drive the market for cardiac markers.

By Mode - Global Point of Care Testing Market & Forecast

On the basis of mode, the point of care testing market is dominated by OTC-based testing segment. The segment is dominating the overall POCT market in 2021 as these tests are cost-effective as well as easy operative in nature. High segmental growth is attributed to rising number of OTC testing such as blood glucose tests and pregnancy tests that provides result in few seconds. These tests do not require skilled professional to perform and can be self-tested by individuals, thereby boosting the market growth. The Prescription based testing segment is expected to grow at the highest rate during the forecast period.

By Platform - Global Point of Care Testing Market & Forecast

By platform, the Lateral Flow Assays (LFA) segment accounted for largest revenue share in 2021. POC tests based on lateral flow assays are increasingly being employed to replace long, conventional laboratory processes. Lateral flow assays are simple devices used to detect the presence or absence of target analytes in samples. These assays help in detecting and quantifying analytes in complex mixtures and provide results within 30 minutes after the sample is placed on the device. The point of care testing market for immunoassays technology is expected to witness significant growth over the forecast timeframe. Rapid immunoassays improve quality of care through its performance at point of care facilities, such as student health clinics, labor and delivery suites and emergency rooms. The cost-effectiveness offered by these immunoassays will influence segment growth during the forecast period.

By End Users - Global Point of Care Testing Market & Forecast

Based on end users, the point of care testing market is segmented into Hospitals, Clinics, Laboratories, Home Care and Assisted Living Healthcare Facilities. Hospitals held majority of the point of care testing market, followed by Clinics. Increase in prevalence of chronic conditions such as cancer and cardiovascular diseases that require proper monitoring and prefer minimally invasive procedures are carried out in hospitals and clinics. The home care segment is expected to grow at the highest rate during the forecast period driven by increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.

By Region - Global Point of Care Testing Market & Forecast

The point of care testing market, by region, is dominated by North America and is expected to maintain its position throughout the forecast period. This can be attributed to rising prevalence of chronic disorders and infectious diseases, which need portable and rapid diagnosis, increasing number of product approvals, and rising government initiatives to support the adoption of POCT in this region. Europe held second highest share of the point of care testing market. Asia-Pacific point of care testing market is expected to grow at the fastest rate during the forecast period driven by growing geriatric population base, rising prevalence of target diseases, increasing demand for home healthcare and the introduction of new products enabled with advanced technologies.

iGATE RESEARCH report titled "Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028" provides a comprehensive analysis of the Global Point of Care Testing Market.

This 270 Page report with 78 Figures and 12 Tables has been analyzed from 11 View Points:

1) Global - Point of Care Testing Market & Forecast (2010 - 2028)

2) Impact of COVID-19 on Global Point of Care Testing Market

3) Global - Point of Care Testing Market Share and Forecast (2010 - 2028)

4) By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)

5) By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)

6) By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)

7) By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)

8) By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)

9) Global Point of Care Testing Market - Recent Developments

10) Global Point of Care Testing Market - 106 Company Profiles

11) Global Point of Care Testing Market - Growth Drivers & Challenges

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

1. Blood Glucose Testing

2. Cardiac Marker Testing

3. Lipid Panel/Cholesterol Testing

4. Coagulation Testing

5. Infectious Disease Testing

6. Urinalysis Testing

7. Drug of Abuse Testing

8. Fecal Occult Blood Testing

9. Pregnancy & Fertility Testing

10. Tumor Marker Testing

11. Critical Care Testing

12. HbA1c Testing

13. Clinical Chemistry Testing

14. Bilirubin Testing

15. Hematology Testing

By Mode - Global Point of Care Testing Market & Forecast

  • Prescription-based Testing
  • OTC-based Testing

By Platform - Global Point of Care Testing Market & Forecast

  • Lateral Flow Assays
  • Immunoassays
  • Microfluidics
  • Dipsticks
  • Molecular Diagnostics
  • Others

By End Users - Global Point of Care Testing Market & Forecast

1. Hospitals

2. Clinics

3. Laboratories

4. Assisted Living Healthcare Facilities

5. Home Care

By Region - Global Point of Care Testing Market & Forecast

1. North America

2. Europe

3. Asia Pacific

4. Latin America

5. Middle East & Africa

Global Point of Care Testing Market - 106 Company Profiles

1. Abbott Laboratories 2. Siemens Healthineers 3. Roche Diagnostics 4. Quest Diagnostics 5. Becton, Dickinson and Company 6. ACON Laboratories 7. Abaxis, Inc 8. Abingdon Health, Ltd 9. Access Bio, Inc. 10. AccuBioTech Co, Ltd. 11. Akers Biosciences, Inc. 12. Alfa Scientific Designs, Inc 13. American Bio Medica Corporation 14. AmniSure International 15. Aquila Diagnostic Systems, Inc 16. ARKRAY Inc 17. Artron Laboratories Inc. 18. Ascensia Diabetes Care Holdings AG 19. Immune IQ (Formerly Ativa) 20. Atlas Link Biotech Co., Ltd 21. Audit Diagnostics 22. Augurix Diagnostics 23. Autobio Diagnostics Co., Ltd 24. Axxin 25. Beckman Coulter, Inc 26. Bhat Bio-Tech India Private Ltd. 27. bioLytical Laboratories 28. BioMedomics, Inc 29. Biomerica, Inc. 30. bioMerieux SA 31. Biophor Diagnostics, Inc 32. Bio-Rad Laboratories Inc. 33. Bioscan Screening Systems, Inc. 34. Biosensia Ltd. 35. BTNX Inc. 36. Boditech Med Inc 37. Xiamen Boson Biotech Co. Ltd 38. Calypte Biomedical Corporation 39. Cepheid, Inc 40. Chembio Diagnostic Systems, Inc 41. Clarity Diagnostics, LLC 42. Confirm Biosciences 43. CTK Biotech, Inc. 44. Daktari Diagnostics 45. Danaher Corporation 46. Dexcom, Inc 47. DIALAB GmbH 48. DiaSys Diagnostic Systems GmbH 49. Diazyme Laboratories, Inc. 50. DNA Electronics Ltd. (DNAe) 51. EKF Diagnostics Holdings plc 52. ELITechGroup, Inc. 53. Eurolyser Diagnostica GmbH 54. Exact Sciences Corporation 55. Exalenz Bioscience Ltd 56. Genedrive plc 57. GeTein BioMedical, Inc. 58. Helena Laboratories 59. Hemosure, Inc. 60. Immunostics, Inc. 61. Instrumentation Laboratory 62. JAL Innovation PTE LTD 63. Jant Pharmacal Corporation 64. LamdaGen Corporation 65. LifeScan, Inc 66. LifeSign, LLC 67. MBio Diagnostics, Inc (Now LightDeck Diagnostics) 68. Medix Biochemica 69. Medtronic, Inc 70. A. Menarini Diagnostics S.R.L. 71. Meridian Bioscience, Inc 72. Nano-Ditech Corporation 73. Noble Medical, Inc 74. Nova Biomedical, Corp. 75. Oasis Diagnostics Corporation 76. OPKO Health, Inc 77. OPTI Medical Systems, Inc 78. OraSure Technologies, Inc 79. Polymed Therapeutics Inc. 80. Preventis GmbH 81. Princeton Biomeditech Corporation 82. QuantuMDx Group Limited 83. Radiometer Medical A/S 84. Response Biomedical Corp 85. Reszon Diagnostics International Sdn. Bhd. 86. Samsung Healthcare 87. Savyon Diagnostics 88. Sekisui Diagnostics LLC 89. Siloam Biosciences, Inc 90. Sysmex Corporation 91. TECHLAB, Inc. 92. Teco Diagnostics 93. Trinity Biotech PLC 94. Trividia Health 95. Tulip Diagnostics Ltd 96. Veredus Laboratories PTE Ltd 97. Vircell 98. WAMA Diagnostica 99. Wave 80 Biosciences 100. Werfen 101. Quidel Corporation 102. Thermo Fisher Scientific 103. Mesa Biotech Inc 104. GeneSTAT Molecular Diagnostics, LLC 105. Biocartis Group NV 106. Johnson and Johnson Service, Inc.

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Point of Care Testing Market

3. Global - Point of Care Testing Market & Forecast (2010 - 2028)

4. Global - Point of Care Testing Market Share & Forecast (2010 - 2028)

  • 4.1 By Diagnostics Segment - Global Point of Care Testing Market Share & Forecast
  • 4.2 By Mode - Global Point of Care Testing Market Share & Forecast
  • 4.3 By Platform - Global Point of Care Testing Market Share & Forecast (2015 - 2028)
  • 4.4 By End Users - Global Point of Care Testing Market Share & Forecast
  • 4.5 By Region - Point of Care Testing Market Share & Forecast

5. By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)

  • 5.1 Blood Glucose Testing Market & Forecast
  • 5.2 Cardiac Marker Testing Market & Forecast
  • 5.3 Lipid Panel/Cholesterol Testing Market & Forecast
  • 5.4 Coagulation Testing Market & Forecast
  • 5.5 Infectious Disease Testing Market & Forecast
  • 5.6 Urinalysis Testing Market & Forecast
  • 5.7 Drug of Abuse Testing Market & Forecast
  • 5.8 Fecal Occult Blood Testing Market & Forecast
  • 5.9 Pregnancy & Fertility Testing Market & Forecast
  • 5.10 Tumor Marker Testing Market & Forecast
  • 5.11 Critical Care Testing Market & Forecast
  • 5.12 HbA1c Testing Market & Forecast
  • 5.13 Clinical Chemistry Testing Market & Forecast
  • 5.14 Bilirubin Testing Market & Forecast
  • 5.15 Hematology Testing Market & Forecast

6. By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)

  • 6.1 Prescription-based Testing Market & Forecast
  • 6.2 OTC-based Testing Market & Forecast

7. By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)

  • 7.1 Global - Point of Care Diagnostics Market for Lateral Flow Assays
  • 7.2 Global - Point of Care Diagnostics Market for Immunoassays
  • 7.3 Global - Point of Care Diagnostics Market for Microfluidics
  • 7.4 Global - Point of Care Diagnostics Market for Dipsticks
  • 7.5 Global - Point of Care Diagnostics Market for Molecular Diagnostics
  • 7.6 Global - Point of Care Diagnostics Market for Other Platforms

8. By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)

  • 8.1 Hospitals - Point of Care Testing Market & Forecast
  • 8.2 Clinics - Point of Care Testing Market & Forecast
  • 8.3 Laboratories - Point of Care Testing Market & Forecast
  • 8.4 Assisted Living Healthcare Facilities - Point of Care Testing Market & Forecast
  • 8.5 Home Care - Point of Care Testing Market & Forecast

9. By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)

  • 9.1 North America - Point of Care Testing Market & Forecast
  • 9.2 Europe - Point of Care Testing Market & Forecast
  • 9.3 Asia Pacific - Point of Care Testing Market & Forecast
  • 9.4 Latin America - Point of Care Testing Market & Forecast
  • 9.5 Middle East and Africa - Point of Care Testing Market & Forecast

10. Global Point of Care Testing Market - Recent Developments

11. Point of Care Testing Market - Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Company Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Financial Insight
    • 11.1.4 Business Strategy
  • 11.2 Siemens Healthineers
    • 11.2.1 Company Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Financial Insight
    • 11.2.4 Business Strategy
  • 11.3 Roche Diagnostics
    • 11.3.1 Company Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Financial Insight
    • 11.3.4 Business Strategy
  • 11.4 Quest Diagnostics
    • 11.4.1 Company Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Financial Insight
    • 11.4.4 Business Strategy
  • 11.5 Becton, Dickinson and Company
    • 11.5.1 Company Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Financial Insight
    • 11.5.4 Business Strategy
  • 11.6 ACON Laboratories
    • 11.6.1 Company Overview
    • 11.6.2 Product Portfolio
  • 11.7 Abaxis, Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Product Portfolio
  • 11.8 Abingdon Health, Ltd.
    • 11.8.1 Company Overview
    • 11.8.2 Product Portfolio
  • 11.9 Access Bio, Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Product Portfolio
  • 11.10 AccuBioTech Co, Ltd.
  • 11.11 Akers Biosciences, Inc.
  • 11.12 Alfa Scientific Designs, Inc
  • 11.13 American Bio Medica Corporation
  • 11.14 AmniSure International
  • 11.15 Aquila Diagnostic Systems, Inc
  • 11.16 ARKRAY Inc
  • 11.17 Artron Laboratories Inc.
  • 11.18 Ascensia Diabetes Care Holdings AG
  • 11.19 Immune IQ (Formerly Ativa)
  • 11.20 Atlas Link Biotech Co., Ltd
  • 11.21 Audit Diagnostics
  • 11.22 Augurix Diagnostics
  • 11.23 Autobio Diagnostics Co., Ltd
  • 11.24 Axxin
  • 11.25 Beckman Coulter, Inc
  • 11.26 Bhat Bio-Tech India Private Ltd. (BBI)
  • 11.27 bioLytical Laboratories
  • 11.28 BioMedomics, Inc
  • 11.29 Biomerica, Inc.
  • 11.30 bioMerieux SA
  • 11.31 Biophor Diagnostics, Inc
  • 11.32 Biosensia Ltd.
  • 11.33 Bio-Rad Laboratories Inc.
  • 11.34 Bioscan Screening Systems, Inc.
  • 11.35 BTNX Inc.
  • 11.36 Boditech Med Inc
  • 11.37 Xiamen Boson Biotech Co. Ltd
  • 11.38 Calypte Biomedical Corporation
  • 11.39 Cepheid, Inc
  • 11.40 Chembio Diagnostic Systems, Inc.
  • 11.41 Clarity Diagnostics, LLC
  • 11.42 Confirm Biosciences
  • 11.43 CTK Biotech, Inc.
  • 11.44 Daktari Diagnostics
  • 11.45 Danaher Corporation
  • 11.46 Dexcom, Inc
  • 11.47 DIALAB GmbH
  • 11.48 DiaSys Diagnostic Systems GmbH
  • 11.49 Diazyme Laboratories, Inc.
  • 11.50 DNA Electronics Ltd. (DNAe)
  • 11.51 EKF Diagnostics Holdings plc
  • 11.52 ELITechGroup, Inc.
  • 11.53 Eurolyser Diagnostica GmbH
  • 11.54 Exact Sciences Corporation
  • 11.55 Exalenz Bioscience Ltd.
  • 11.56 Genedrive plc
  • 11.57 GeTein BioMedical, Inc.
  • 11.58 Helena Laboratories
  • 11.59 Hemosure, Inc.
  • 11.60 Immunostics, Inc.
  • 11.61 Instrumentation Laboratory
  • 11.62 JAL Innovation PTE LTD
  • 11.63 Jant Pharmacal Corporation
  • 11.64 LamdaGen Corporation
  • 11.65 LifeScan, Inc
  • 11.66 LifeSign, LLC
  • 11.67 MBio Diagnostics, Inc (Now LightDeck Diagnostics)
  • 11.68 Medix Biochemica
  • 11.69 Medtronic, Inc.
  • 11.70 A. Menarini Diagnostics S.R.L.
  • 11.71 Meridian Bioscience, Inc
  • 11.72 Nano-Ditech Corporation
  • 11.73 Noble Medical, Inc
  • 11.74 Nova Biomedical, Corp.
  • 11.75 Oasis Diagnostics Corporation
  • 11.76 OPKO Health, Inc
  • 11.77 OPTI Medical Systems, Inc
  • 11.78 OraSure Technologies, Inc
  • 11.79 Polymed Therapeutics Inc.
  • 11.80 Preventis GmbH
  • 11.81 Princeton Biomeditech Corporation
  • 11.82 QuantuMDx Group Limited
  • 11.83 Radiometer Medical A/S
  • 11.84 Response Biomedical Corp
  • 11.85 Reszon Diagnostics International Sdn. Bhd.
  • 11.86 Samsung Healthcare
  • 11.87 Savyon Diagnostics
  • 11.88 Sekisui Diagnostics LLC
  • 11.89 Siloam Biosciences, Inc
  • 11.90 Sysmex Corporation
  • 11.91 TECHLAB, Inc.
  • 11.92 Teco Diagnostics
  • 11.93 Trinity Biotech PLC
  • 11.94 Trividia Health
  • 11.95 Tulip Diagnostics Ltd
  • 11.96 Veredus Laboratories PTE Ltd
  • 11.97 Vircell
  • 11.98 WAMA Diagnostica
  • 11.99 Wave 80 Biosciences
  • 11.100 Werfen
  • 11.101 Quidel Corporation
  • 11.102 Thermo Fisher Scientific
  • 11.103 Mesa Biotech Inc.
  • 11.104 GeneSTAT Molecular Diagnostics, LLC
  • 11.105 Biocartis Group NV
  • 11.106 Johnson and Johnson Service, Inc.

12. Global Point of Care Testing Market - Growth Drivers

  • 12.1 Point-of-care Testing: A Step to the Future
  • 12.2 High Prevalence of Chronic and Infectious Diseases
  • 12.3 Continued Expansion of Point of Care Including Self Testing
    • 12.3.1 The Promise of Point-of-Care Testing
    • 12.3.2 Future of Point of Care Testing - The 'Worried Well'
    • 12.3.3 Hub and Spoke
    • 12.3.4 Education
  • 12.4 Technological Advancement in POCT to Spur Market Demand

13. Global Point of Care Testing Market - Challenges

  • 13.1 Point of Care (POC) Testing Barriers in Low & Middle-Income Countries
    • 13.1.1 Barriers to Adoption & Scale-up of POC Technologies
    • 13.1.2 Technical, Administrative & Operational Barriers of Point of Care Tests
    • 13.1.3 Health System Related Barriers of Point of Care Tests
    • 13.1.4 Economic Barriers of Point of Care Tests
  • 13.2 Policy/Regulatory Guidelines and Funding Challenges
  • 13.3 Infrastructure Barriers and Challenges with POC Diagnostics Development